StonvexLoading…
StonvexStonvexStonvexCore line items from MSAI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.61M | $5.55M | $4.16M | $2.59M |
Operating Income | $-2.59M | $-12.01M | $-9.63M | $-7.93M |
Net Income | $-2.47M | $-11.71M | $-9.44M | $-3.32M |
EPS (Diluted) | $-1.23 | $-0.31 | $-0.28 | $-0.23 |
Total Assets | $32.84M | $35.47M | $11.87M | $14.63M |
Total Liabilities | $3.12M | $3.44M | $3.59M | $4.88M |
Cash & Equivalents | $22.55M | $24.36M | $1.06M | $3.19M |
Free Cash Flow OCF − CapEx | $-1.81M | $-9.65M | $-7.05M | $-4.91M |
Shares Outstanding | 2.01M | 2.01M | 34.71M | 34.07M |